Novel Agents in Elderly CLL Patients: Should the Approach be Different?

Skip Ad in 6 Seconds

Browse Other Featured Videos

CAR T-Cell Therapy: Engineering the body’s immune system to fight cancer

December 26th, 2019    1255 Views

Risk stratification in metastatic seminoma

March 3rd, 2020    70 Views

Inspiring Discussions on Cytogenetics

Better IHC Step 1: Antigen Retrieval

April 3rd, 2019    1648 Views

Is the Study of Monogenic Diseases of the Immune System Relevant?

March 8th, 2020    575 Views

New Disease Research

Update: Relapsed/Refractory Follicular Lymphoma

May 22nd, 2019    1216 Views

Minimal residual disease: a key determinant of ALL treatment response

May 17th, 2018    121 Views

Research in Diagnostic and Treatment Techniques

Emerging immunotherapy modalities in AML and exciting data from ASH 2019

December 18th, 2019    230 Views

Dr. O’Reilly on the Role of Germline Testing in Pancreatic Cancer

April 6th, 2020    41 Views

Gene Inhibitors in Cancer

Optimizing the Use of BCR-ABL TKIs in CML

August 16th, 2018    113 Views

Practical Considerations With Checkpoint Inhibitors in Bladder Cancer

January 16th, 2018    106 Views

Gene Mutation and Gene Fusion Research

What is Familial Adenomatous Polyposis (FAP)?

April 5th, 2017    3861 Views

Dr. Grupka on Mutations in Patients With Myelodysplastic Syndrome

February 23rd, 2018    131 Views

Featured Videos from Sponsors

Bone Marrow & Blood Protocol Optimization Tips

March 19th, 2020    326 Views

FFPE Slide Optimization Tips & Tricks

February 28th, 2020    289 Views